Aaron Joel Goldman, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Barrett Esophagus | 8 | 2011 | 494 | 0.960 |
Why?
|
| Esophagus | 3 | 2011 | 1041 | 0.710 |
Why?
|
| Bile Acids and Salts | 4 | 2011 | 398 | 0.700 |
Why?
|
| Socialization | 1 | 2019 | 88 | 0.660 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2019 | 126 | 0.640 |
Why?
|
| Drug Delivery Systems | 3 | 2020 | 2212 | 0.620 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2019 | 209 | 0.600 |
Why?
|
| Drug Resistance, Neoplasm | 7 | 2020 | 5332 | 0.590 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2020 | 422 | 0.580 |
Why?
|
| Antineoplastic Agents | 8 | 2020 | 13650 | 0.580 |
Why?
|
| Nanoparticles | 6 | 2020 | 1966 | 0.520 |
Why?
|
| Neurosciences | 1 | 2019 | 384 | 0.480 |
Why?
|
| Neoplasm Proteins | 4 | 2019 | 3599 | 0.460 |
Why?
|
| Social Behavior | 1 | 2019 | 1147 | 0.420 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1085 | 0.400 |
Why?
|
| Behavior, Animal | 1 | 2019 | 1865 | 0.380 |
Why?
|
| Amygdala | 1 | 2019 | 1375 | 0.380 |
Why?
|
| Deoxycholic Acid | 1 | 2011 | 54 | 0.380 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 2209 | 0.370 |
Why?
|
| Enzyme Inhibitors | 2 | 2019 | 3726 | 0.360 |
Why?
|
| Cations | 1 | 2011 | 239 | 0.360 |
Why?
|
| Models, Biological | 5 | 2019 | 9464 | 0.360 |
Why?
|
| Neoplasms | 9 | 2019 | 22350 | 0.320 |
Why?
|
| Glucose | 1 | 2019 | 4341 | 0.290 |
Why?
|
| Mice, Inbred BALB C | 5 | 2020 | 6226 | 0.280 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 7611 | 0.250 |
Why?
|
| Anxiety | 1 | 2019 | 4670 | 0.230 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2018 | 572 | 0.230 |
Why?
|
| Cyclic AMP | 2 | 2018 | 1472 | 0.230 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2011 | 957 | 0.220 |
Why?
|
| Cell Line, Tumor | 9 | 2020 | 17097 | 0.210 |
Why?
|
| Esophageal Neoplasms | 4 | 2016 | 1661 | 0.200 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2011 | 2478 | 0.200 |
Why?
|
| DNA Damage | 2 | 2011 | 2469 | 0.190 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2016 | 754 | 0.190 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 5389 | 0.180 |
Why?
|
| Symporters | 1 | 2023 | 363 | 0.170 |
Why?
|
| Nanocapsules | 1 | 2020 | 92 | 0.170 |
Why?
|
| Drug Compounding | 1 | 2020 | 236 | 0.160 |
Why?
|
| Macrolides | 1 | 2020 | 204 | 0.160 |
Why?
|
| Mice, Inbred DBA | 1 | 2019 | 624 | 0.160 |
Why?
|
| Drug Resistance, Multiple | 1 | 2019 | 255 | 0.150 |
Why?
|
| Proton Pump Inhibitors | 3 | 2011 | 551 | 0.150 |
Why?
|
| Apoptosis | 3 | 2016 | 9513 | 0.140 |
Why?
|
| Ribonuclease III | 1 | 2019 | 271 | 0.140 |
Why?
|
| Status Epilepticus | 1 | 2023 | 459 | 0.140 |
Why?
|
| Second Messenger Systems | 1 | 2018 | 203 | 0.140 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2019 | 385 | 0.130 |
Why?
|
| Computer Simulation | 2 | 2020 | 6260 | 0.130 |
Why?
|
| Shear Strength | 1 | 2016 | 159 | 0.130 |
Why?
|
| Monitoring, Immunologic | 1 | 2016 | 99 | 0.130 |
Why?
|
| Reactive Oxygen Species | 2 | 2016 | 2144 | 0.130 |
Why?
|
| Drug Resistance, Microbial | 1 | 2018 | 831 | 0.120 |
Why?
|
| Tumor Microenvironment | 2 | 2020 | 3944 | 0.120 |
Why?
|
| Microfluidics | 1 | 2020 | 650 | 0.120 |
Why?
|
| Coculture Techniques | 1 | 2019 | 1337 | 0.120 |
Why?
|
| Nanotechnology | 1 | 2020 | 702 | 0.120 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 13491 | 0.120 |
Why?
|
| Breast Neoplasms | 3 | 2020 | 21178 | 0.110 |
Why?
|
| Cytoplasm | 1 | 2018 | 1504 | 0.110 |
Why?
|
| Membrane Microdomains | 1 | 2015 | 205 | 0.110 |
Why?
|
| Nanomedicine | 1 | 2016 | 289 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2019 | 10455 | 0.110 |
Why?
|
| Disease | 1 | 2018 | 675 | 0.110 |
Why?
|
| Ascorbic Acid | 1 | 2016 | 658 | 0.100 |
Why?
|
| Adaptation, Physiological | 1 | 2019 | 1312 | 0.100 |
Why?
|
| Chemoprevention | 2 | 2011 | 327 | 0.100 |
Why?
|
| Animals | 11 | 2023 | 168965 | 0.100 |
Why?
|
| Stress, Mechanical | 1 | 2016 | 1673 | 0.090 |
Why?
|
| Taxoids | 1 | 2015 | 665 | 0.090 |
Why?
|
| Drug Carriers | 1 | 2016 | 702 | 0.090 |
Why?
|
| Cholesterol | 1 | 2020 | 2905 | 0.090 |
Why?
|
| Receptors, Notch | 1 | 2016 | 751 | 0.090 |
Why?
|
| Neoplasm Metastasis | 2 | 2019 | 4892 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 2 | 2020 | 2824 | 0.090 |
Why?
|
| Hydrogen | 1 | 2011 | 168 | 0.090 |
Why?
|
| Hydrochloric Acid | 1 | 2010 | 76 | 0.090 |
Why?
|
| Acids | 1 | 2010 | 125 | 0.090 |
Why?
|
| Drug Monitoring | 1 | 2016 | 963 | 0.080 |
Why?
|
| Metaplasia | 1 | 2010 | 326 | 0.080 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 1331 | 0.080 |
Why?
|
| Adenocarcinoma | 3 | 2011 | 6360 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 861 | 0.080 |
Why?
|
| Signal Transduction | 5 | 2018 | 23621 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2018 | 2627 | 0.080 |
Why?
|
| Superoxide Dismutase | 1 | 2010 | 596 | 0.070 |
Why?
|
| Cation Transport Proteins | 1 | 2010 | 325 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2015 | 5693 | 0.070 |
Why?
|
| Humans | 25 | 2020 | 767040 | 0.070 |
Why?
|
| Nitric Oxide Synthase | 1 | 2010 | 911 | 0.070 |
Why?
|
| Computational Biology | 1 | 2019 | 3567 | 0.070 |
Why?
|
| Neoplastic Stem Cells | 1 | 2015 | 1349 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2016 | 3642 | 0.070 |
Why?
|
| STAT3 Transcription Factor | 1 | 2010 | 872 | 0.070 |
Why?
|
| Drug Synergism | 1 | 2010 | 1759 | 0.070 |
Why?
|
| Sodium | 1 | 2011 | 1594 | 0.060 |
Why?
|
| Epithelium | 1 | 2010 | 1606 | 0.060 |
Why?
|
| Lysosomes | 1 | 2011 | 937 | 0.060 |
Why?
|
| Drug Resistance | 1 | 2010 | 1592 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2020 | 4745 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2010 | 3587 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2015 | 4032 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 22361 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2010 | 2931 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4572 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2010 | 2493 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2010 | 4143 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2010 | 2140 | 0.050 |
Why?
|
| Endoscopy | 1 | 2011 | 1854 | 0.050 |
Why?
|
| Cell Survival | 3 | 2016 | 5750 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2010 | 3227 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18330 | 0.040 |
Why?
|
| Mice | 4 | 2023 | 81912 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2013 | 3986 | 0.040 |
Why?
|
| rap GTP-Binding Proteins | 1 | 2018 | 24 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 10748 | 0.040 |
Why?
|
| Female | 6 | 2020 | 396660 | 0.040 |
Why?
|
| Mutation | 2 | 2019 | 30211 | 0.040 |
Why?
|
| Agriculture | 1 | 2018 | 186 | 0.040 |
Why?
|
| Stochastic Processes | 1 | 2018 | 359 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 9108 | 0.040 |
Why?
|
| Telomere-Binding Proteins | 1 | 2018 | 122 | 0.030 |
Why?
|
| Benzodiazepines | 1 | 2023 | 1137 | 0.030 |
Why?
|
| Phenotype | 1 | 2015 | 16718 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2023 | 1139 | 0.030 |
Why?
|
| Cell Line | 1 | 2010 | 15567 | 0.030 |
Why?
|
| Esterases | 1 | 2016 | 89 | 0.030 |
Why?
|
| Cell Movement | 2 | 2018 | 5203 | 0.030 |
Why?
|
| Catalase | 1 | 2016 | 215 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2011 | 18989 | 0.030 |
Why?
|
| Algorithms | 1 | 2016 | 14098 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2018 | 482 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2010 | 12793 | 0.030 |
Why?
|
| Microvessels | 1 | 2018 | 585 | 0.030 |
Why?
|
| Biological Transport | 1 | 2018 | 2084 | 0.030 |
Why?
|
| Electric Impedance | 1 | 2018 | 792 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2016 | 730 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2016 | 426 | 0.030 |
Why?
|
| Time Factors | 1 | 2015 | 40154 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2018 | 935 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2016 | 740 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2018 | 1029 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2018 | 3093 | 0.020 |
Why?
|
| Necrosis | 1 | 2016 | 1614 | 0.020 |
Why?
|
| Brain | 1 | 2018 | 27163 | 0.020 |
Why?
|
| Cell Communication | 1 | 2018 | 1660 | 0.020 |
Why?
|
| Nanostructures | 1 | 2016 | 549 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2013 | 2168 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2011 | 163 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2018 | 5022 | 0.020 |
Why?
|
| Cell Death | 1 | 2016 | 1677 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2016 | 1195 | 0.020 |
Why?
|
| Communicable Diseases | 1 | 2018 | 872 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2016 | 1903 | 0.020 |
Why?
|
| Seizures | 1 | 2023 | 2996 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 2628 | 0.020 |
Why?
|
| Polymers | 1 | 2016 | 1624 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2016 | 1728 | 0.020 |
Why?
|
| Disease Progression | 2 | 2018 | 13646 | 0.020 |
Why?
|
| Antioxidants | 1 | 2016 | 1671 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2016 | 1928 | 0.020 |
Why?
|
| Cisplatin | 1 | 2013 | 1656 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 6106 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2018 | 3582 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 3608 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 11063 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 2457 | 0.010 |
Why?
|
| Prevalence | 2 | 2011 | 15851 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2016 | 3561 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 2883 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 4560 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2011 | 1794 | 0.010 |
Why?
|
| Incidence | 2 | 2011 | 21526 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2016 | 65295 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 2429 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2011 | 2856 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 9551 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 20169 | 0.010 |
Why?
|
| Male | 1 | 2016 | 364203 | 0.000 |
Why?
|